Patents-Review.com
🔗 Permalink
Assignee profile:

UCB BIOPHARMA SPRL

City:

Brussels

Country:

Belgium

Published Applications:

144

Last publication date:

2022-05-26

Patent Grants:

135

Last grant date:

2022-05-10

Top Inventors for applications by UCB BIOPHARMA SPRL

These are the the leading inventors for applications assigned to UCB BIOPHARMA SPRL:

Recent patent applications by UCB BIOPHARMA SPRL

UCB BIOPHARMA SPRL based in Brussels, BE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-05-26
US20220162311A1
Chemistry; metallurgy

ANTIBODIES SPECIFIC TO FCRN

 #2 | 2021-12-02
US20210371547A1
Chemistry; metallurgy

BIOLOGICAL PRODUCTS

 #3 | 2020-12-03
US20200377578A1
Chemistry; metallurgy

NEUTRALISING ANTIBODIES TO THE MAJOR EXOTOXINS TCDA AND TCDB OF CLOSTRIDIUM DIFFICILE

 #4 | 2020-10-01 ✅ Patent 11,324,896 granted on 2022-05-10
US20200306461A1
Human necessities

Cap for an injector

 #5 | 2020-09-17 ✅ Patent 11,091,474 granted on 2021-08-17
US20200291013A1
Chemistry; metallurgy

Alkoxy bis-heteroaryl derivatives as modulators of protein aggregation

 #6 | 2020-09-03
US20200277366A1
Chemistry; metallurgy

MULTI-SPECIFIC ANTIBODY MOLECULES HAVING SPECIFICITY FOR TNF-ALPHA, IL-17A and IL-17F

 #7 | 2020-06-18 ✅ Patent 11,331,438 granted on 2022-05-17
US20200188607A1
Human necessities

Cap for an injector

 #8 | 2020-03-26 ✅ Patent 11,059,820 granted on 2021-07-13
US20200095246A1
Chemistry; metallurgy

Crystalline forms of seletalisib

 #9 | 2019-12-05 ✅ Patent 10,889,584 granted on 2021-01-12
US20190367513A1
Chemistry; metallurgy

Bicyclic bis-heteroaryl derivatives as modulators of protein aggregation

 #10 | 2019-12-05 ✅ Patent 10,913,735 granted on 2021-02-09
US20190367502A1
Chemistry; metallurgy

Bis-heteroaryl derivatives as modulators of protein aggregation

 #11 | 2019-10-10 ✅ Patent 11,078,196 granted on 2021-08-03
US20190308965A1
Chemistry; metallurgy

Heteroaryl amides as inhibitors of protein aggregation

 #12 | 2019-09-19 ✅ Patent 10,889,640 granted on 2021-01-12
US20190284267A1
Chemistry; metallurgy

Tau-binding antibodies

 #13 | 2019-09-05 ✅ Patent 11,220,547 granted on 2022-01-11
US20190270811A1
Chemistry; metallurgy

Antibodies specific to FCRN

 #14 | 2019-08-15 ✅ Patent 11,384,148 granted on 2022-07-12
US20190248890A1
Chemistry; metallurgy

Anti-FcRn antibodies

 #15 | 2019-05-30 ✅ Patent 11,014,979 granted on 2021-05-25
US20190161536A1
Chemistry; metallurgy

Anti-AP2 antibodies and antigen binding agents to treat metabolic disorders

 #16 | 2019-04-25 ✅ Patent 10,421,717 granted on 2019-09-24
US20190119206A1
Chemistry; metallurgy

Process for preparing brivaracetam

 #17 | 2019-04-18 ✅ Patent 10,793,578 granted on 2020-10-06
US20190112314A1
Chemistry; metallurgy

Fused pentacyclic imidazole derivatives as modulators of TNF activity

 #18 | 2019-04-11 ✅ Patent 10,370,355 granted on 2019-08-06
US20190106406A1
Chemistry; metallurgy

Tetrahydroisoquinoline derivatives

 #19 | 2019-04-04 ✅ Patent 10,766,906 granted on 2020-09-08
US20190100526A1
Chemistry; metallurgy

Fused hexacyclic imidazole derivatives as modulators of TNF activity

 #20 | 2019-02-07 ✅ Patent 10,464,932 granted on 2019-11-05
US20190040053A1
Chemistry; metallurgy

Iminothiadiazinane dioxide derivatives as plasmepsin V inhibitors

 #21 | 2018-12-20 ✅ Patent 10,450,320 granted on 2019-10-22
US20180362532A1
Chemistry; metallurgy

Hexahydropyrazinotriazinone derivatives as kinase inhibitors

 #22 | 2018-11-22 ✅ Patent 10,483,684 granted on 2019-11-19
US20180337485A1
Electricity

Housing for a USB connector plug

 #23 | 2018-11-22 ✅ Patent 10,618,979 granted on 2020-04-14
US20180334513A1
Chemistry; metallurgy

Multispecific antibodies

 #24 | 2018-10-18 ✅ Patent 10,472,362 granted on 2019-11-12
US20180298006A1
Chemistry; metallurgy

Fused tricyclic imidazo pyrazines as modulators of TNF activity

 #25 | 2018-09-27 ✅ Patent 10,590,197 granted on 2020-03-17
US20180273620A1
Chemistry; metallurgy

Antibody molecules which bind CD22

 #26 | 2018-07-19 ✅ Patent 10,618,957 granted on 2020-04-14
US20180201678A1
Chemistry; metallurgy

Antibody molecules which bind CD79

 #27 | 2018-07-19 ✅ Patent 10,287,343 granted on 2019-05-14
US20180201666A1
Chemistry; metallurgy

Tau-binding antibodies

 #28 | 2018-07-12 ✅ Patent 10,344,081 granted on 2019-07-09
US20180194832A1
Chemistry; metallurgy

Tau-binding antibodies

 #29 | 2018-06-14 ✅ Patent 10,421,814 granted on 2019-09-24
US20180162947A1
Chemistry; metallurgy

Antibodies

 #30 | 2018-05-24 ✅ Patent 10,829,565 granted on 2020-11-10
US20180142039A1
Chemistry; metallurgy

Method for increasing the percentage of monomeric antibody Fab-dsFv multimeric species

 #31 | 2018-05-24 ✅ Patent 10,316,097 granted on 2019-06-11
US20180142026A1
Chemistry; metallurgy

Method for the treatment of epilepsy, epileptogenesis, seizures or convulsions by an anti-colony-stimulating factor 1 receptor (CSF-1R) antibody

 #32 | 2018-05-17 ✅ Patent 10,023,631 granted on 2018-07-17
US20180134774A1
Chemistry; metallurgy

Albumin binding antibodies and binding fragments thereof

 #33 | 2018-05-17 ✅ Patent 10,287,299 granted on 2019-05-14
US20180134728A1
Chemistry; metallurgy

Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as modulators of tumor necrosis factor activity

 #34 | 2018-05-10
US20180127498A1
Chemistry; metallurgy

ANTI-FCRN ANTIBODIES

 #35 | 2018-05-03 ✅ Patent 10,100,130 granted on 2018-10-16
US20180118853A1
Chemistry; metallurgy

Dual specificity antibody fusions

 #36 | 2018-05-03 ✅ Patent 10,828,366 granted on 2020-11-10
US20180117153A1
Human necessities

Method of monomerisation of recombinant antibody molecules

 #37 | 2018-04-19 ✅ Patent 10,342,925 granted on 2019-07-09
US20180104413A1
Human necessities

Auto-injector

 #38 | 2018-04-05 ✅ Patent 10,358,443 granted on 2019-07-23
US20180093979A1
Chemistry; metallurgy

Heteroaryl amides as inhibitors of protein aggregation

 #39 | 2018-04-05 ✅ Patent 10,639,424 granted on 2020-05-05
US20180093041A1
Human necessities

Auto-injector and drive unit therefor

 #40 | 2018-04-05 ✅ Patent 10,493,074 granted on 2019-12-03
US20180092921A1
Human necessities

Specific trifluoroethyl quinoline analogue for use in the treatment of Sjögren's syndrome

 #41 | 2018-02-15 ✅ Patent 10,639,423 granted on 2020-05-05
US20180043097A1
Human necessities

Auto-injector and drive unit therefor

 #42 | 2018-02-08
US20180037646A1
Chemistry; metallurgy

EPITOPES OF IL-17A AND IL-17F AND ANTIBODIES SPECIFIC THERETO

 #43 | 2018-02-01 ✅ Patent 10,039,826 granted on 2018-08-07
US20180028652A1
Human necessities

Pharmaceutical formulation comprising antibodies which bind colony stimulating factor-1 receptor (CSF1R)

 #44 | 2018-01-25
US20180022748A1
Chemistry; metallurgy

9H-PYRROLO-DIPYRIDINE DERIVATIVES

 #45 | 2017-12-21 ✅ Patent 10,358,460 granted on 2019-07-23
US20170362272A1
Chemistry; metallurgy

Protein manufacture

 #46 | 2017-11-30 ✅ Patent 10,626,143 granted on 2020-04-21
US20170342105A1
Chemistry; metallurgy

Method of protein manufacture

 #47 | 2017-11-02 ✅ Patent 9,975,873 granted on 2018-05-22
US20170313677A1
Chemistry; metallurgy

Isoindoline derivatives

 #48 | 2017-10-26 ✅ Patent 10,308,723 granted on 2019-06-04
US20170306052A1
Chemistry; metallurgy

Method of treating inflammation by administering antibody molecules which bind IL-17A and IL-17F

 #49 | 2017-10-26 ✅ Patent 10,202,405 granted on 2019-02-12
US20170305932A1
Chemistry; metallurgy

Fused pentacyclic imidazole derivatives

 #50 | 2017-10-26 ✅ Patent 10,105,359 granted on 2018-10-23
US20170304292A1
Human necessities

Tetrahydroisoquinoline derivatives

 #51 | 2017-07-20 ✅ Patent 10,730,952 granted on 2020-08-04
US20170204183A1
Chemistry; metallurgy

Molecules with specificity for CD45 and CD79

 #52 | 2017-07-20 ✅ Patent 10,370,447 granted on 2019-08-06
US20170204178A1
Chemistry; metallurgy

Molecules with specificity for CD79 and CD22

 #53 | 2017-06-08 ✅ Patent 9,920,052 granted on 2018-03-20
US20170158688A1
Chemistry; metallurgy

Imidazopyridine derivatives as modulators of TNF activity

 #54 | 2017-05-25
US20170145114A1
Chemistry; metallurgy

BIOLOGICAL PRODUCTS

 #55 | 2017-05-11 ✅ Patent 9,969,748 granted on 2018-05-15
US20170129905A1
Chemistry; metallurgy

Fused bicyclic heteroaromatic derivatives as kinase inhibitors

 #56 | 2017-05-11 ✅ Patent 10,053,464 granted on 2018-08-21
US20170129894A1
Chemistry; metallurgy

Triazolopyridazine derivatives as modulators of TNF activity

 #57 | 2017-05-11 ✅ Patent 9,932,334 granted on 2018-04-03
US20170129883A1
Chemistry; metallurgy

Tetrahydroimidazopyridine derivatives as modulators of TNF activity

 #58 | 2017-05-04 ✅ Patent 10,087,180 granted on 2018-10-02
US20170121324A1
Chemistry; metallurgy

Pyrazolo-pyridine derivatives as kinase inhibitors

 #59 | 2017-03-23 ✅ Patent 10,358,493 granted on 2019-07-23
US20170081404A1
Chemistry; metallurgy

Bispecific format suitable for use in high-through-put screening

 #60 | 2017-03-23 ✅ Patent 9,902,720 granted on 2018-02-27
US20170081321A1
Chemistry; metallurgy

Pyrazolopyridine derivatives as modulators of TNF activity

 #61 | 2017-02-02
US20170029505A1
Chemistry; metallurgy

MULTIMERIC FC PROTEINS

 #62 | 2017-01-12 ✅ Patent 9,789,254 granted on 2017-10-17
US20170007763A1
Human necessities

Auto-injector

 #63 | 2017-01-05 ✅ Patent 9,821,123 granted on 2017-11-21
US20170000955A1
Human necessities

Auto-injector

 #64 | 2016-12-29 ✅ Patent 10,273,247 granted on 2019-04-30
US20160376290A1
Chemistry; metallurgy

Imidazothiazole derivatives as modulators of TNF activity

 #65 | 2016-12-29 ✅ Patent 9,714,251 granted on 2017-07-25
US20160376276A1
Chemistry; metallurgy

Imidazotriazine derivatives as modulators of TNF activity

 #66 | 2016-12-29 ✅ Patent 9,873,703 granted on 2018-01-23
US20160376275A1
Chemistry; metallurgy

Imidazopyridazine derivatives as modulators of TNF activity

 #67 | 2016-12-29 ✅ Patent 10,087,179 granted on 2018-10-02
US20160376268A1
Chemistry; metallurgy

Fused tricyclic imidazole derivatives as modulators of TNF activity

 #68 | 2016-12-08 ✅ Patent 9,890,154 granted on 2018-02-13
US20160355509A1
Chemistry; metallurgy

Imidazopyridine derivatives as modulators of TNF activity

 #69 | 2016-11-17 ✅ Patent 10,421,816 granted on 2019-09-24
US20160333105A1
Chemistry; metallurgy

Multivalent antibodies

 #70 | 2016-11-03 ✅ Patent 10,160,798 granted on 2018-12-25
US20160319003A1
Chemistry; metallurgy

Anti-aP2 antibodies and antigen binding agents to treat metabolic disorders

 #71 | 2016-10-20 ✅ Patent 9,890,174 granted on 2018-02-13
US20160304530A1
Chemistry; metallurgy

Fused Tricyclic imidazole derivatives as modulators of TNF activity

 #72 | 2016-10-20 ✅ Patent 9,932,343 granted on 2018-04-03
US20160304523A1
Chemistry; metallurgy

Fused tricyclic benzimidazoles derivatives as modulators of TNF activity

 #73 | 2016-10-20 ✅ Patent 9,834,553 granted on 2017-12-05
US20160304514A1
Chemistry; metallurgy

Tetrahydroimidazopyridine derivatives as modulators of TNF activity

 #74 | 2016-10-20 ✅ Patent 9,926,313 granted on 2018-03-27
US20160304513A1
Chemistry; metallurgy

Imidazopyridine derivatives as modulators of TNF activity

 #75 | 2016-10-20 ✅ Patent 9,850,240 granted on 2017-12-26
US20160304512A1
Chemistry; metallurgy

Triazolopyridine derivatives as modulators of TNF activity

 #76 | 2016-10-20 ✅ Patent 9,969,729 granted on 2018-05-15
US20160304511A1
Chemistry; metallurgy

Imidazopyridine derivatives as modulators of TNF activity

 #77 | 2016-10-20 ✅ Patent 9,815,797 granted on 2017-11-14
US20160304470A1
Chemistry; metallurgy

Fused bicyclic heteroaromatic derivatives as modulators of TNF activity

 #78 | 2016-10-13 ✅ Patent 9,868,749 granted on 2018-01-16
US20160297837A1
Chemistry; metallurgy

Fused imidazole and pyrazole derivatives as modulators of TNF activity

 #79 | 2016-10-13 ✅ Patent 9,932,342 granted on 2018-04-03
US20160297827A1
Chemistry; metallurgy

Imidazopyrimidine derivatives as modulators of TNF activity

 #80 | 2016-10-13 ✅ Patent 9,988,383 granted on 2018-06-05
US20160297818A1
Chemistry; metallurgy

Purine derivatives as modulators of TNF activity

 #81 | 2016-10-13 ✅ Patent 9,957,255 granted on 2018-05-01
US20160297799A1
Chemistry; metallurgy

Benzotriazole derivatives as modulators of TNF activity

 #82 | 2016-10-13 ✅ Patent 10,093,652 granted on 2018-10-09
US20160297795A1
Chemistry; metallurgy

Tetrahydrobenzimidazole derivatives as modulators of TNF activity

 #83 | 2016-10-06 ✅ Patent 9,957,320 granted on 2018-05-01
US20160289323A1
Chemistry; metallurgy

Isolated DNA sequences encoding, and methods for making, antibody molecules having binding specificity for human IL-13

 #84 | 2016-10-06 ✅ Patent 9,969,728 granted on 2018-05-15
US20160289228A1
Chemistry; metallurgy

Tetrahydroimidazopyridine derivatives as modulators of TNF activity

 #85 | 2016-09-15 ✅ Patent 10,273,302 granted on 2019-04-30
US20160264668A1
Chemistry; metallurgy

Antibodies specific to FcRn

 #86 | 2016-08-04 ✅ Patent 10,112,996 granted on 2018-10-30
US20160222107A1
Chemistry; metallurgy

Function modifying NA1.7 antibodies

 #87 | 2016-07-14 ✅ Patent 9,908,939 granted on 2018-03-06
US20160200821A1
Chemistry; metallurgy

Antibodies

 #88 | 2016-07-07 ✅ Patent 10,099,013 granted on 2018-10-16
US20160193414A1
Human necessities

Injector

 #89 | 2016-07-07 ✅ Patent 9,956,274 granted on 2018-05-01
US20160193309A1
Human necessities

Method to generate antibodies to ion channels

 #90 | 2016-06-23 ✅ Patent 10,500,341 granted on 2019-12-10
US20160175531A1
Human necessities

Assembly for an autoinjector device

 #91 | 2016-03-10 ✅ Patent 9,499,603 granted on 2016-11-22
US20160068586A1
Chemistry; metallurgy

PD-1 antibodies

 #92 | 2016-02-11 ✅ Patent 9,631,015 granted on 2017-04-25
US20160039929A1
Chemistry; metallurgy

Methods for treating IL-6 mediated diseases with antibody molecules specific for IL-6

 #93 | 2016-02-04 ✅ Patent 9,873,735 granted on 2018-01-23
US20160031974A1
Chemistry; metallurgy

Method of treatment with antibodies having specificity for human OX40

 #94 | 2016-01-21 ✅ Patent 10,457,748 granted on 2019-10-29
US20160017057A1
Chemistry; metallurgy

Single linker FabFv antibodies and methods of producing same

 #95 | 2015-11-12 ✅ Patent 9,890,219 granted on 2018-02-13
US20150322147A1
Chemistry; metallurgy

Methods of treating an IL-17A mediated pathological condition

 #96 | 2015-11-05 ✅ Patent 9,771,420 granted on 2017-09-26
US20150315272A1
Chemistry; metallurgy

Methods of treating an IL-17A mediated pathological condition

 #97 | 2015-10-01 ✅ Patent 10,759,844 granted on 2020-09-01
US20150274810A1
Chemistry; metallurgy

Disulfide stabilised antibodies and fragments thereof

 #98 | 2015-10-01 ✅ Patent 9,382,263 granted on 2016-07-05
US20150274748A1
Chemistry; metallurgy

Therapeutically active oxazoline derivatives

 #99 | 2015-10-01 ✅ Patent 9,867,941 granted on 2018-01-16
US20150273151A1
Human necessities

Auto-injector and drive unit therefor

 #100 | 2015-09-17 ✅ Patent 9,757,521 granted on 2017-09-12
US20150258278A1
Human necessities

Auto-injector

Also check out UCB BIOPHARMA SPRL's (Brussels, Belgium) applicant profile with 115 patent applications submitted.

AssigneeID:

94143 ⎘